Using light to enhance hand movement after spinal cord injury.
Optogenetics to improve hand function after spinal cord injury.
['FUNDING_R01'] · UNIVERSITY OF WASHINGTON · NIH-10692588
This study is exploring a new way to help people with cervical spinal cord injuries regain better use of their hands and arms by using special light and electrical signals, and it will compare this method to traditional treatments to see which works best.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF WASHINGTON (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-10692588 on ClinicalTrials.gov |
What this research studies
This research aims to improve hand and arm function in individuals with cervical spinal cord injuries by utilizing optogenetic stimulation. The approach involves implanting flexible electrodes that can deliver both light and electrical stimulation to the spinal cord, potentially leading to better recovery outcomes. The study will compare the effectiveness of optogenetic stimulation against traditional electrical stimulation, as well as a combination of both methods. By understanding how these stimulations promote recovery, the research seeks to uncover the underlying mechanisms of spinal cord healing.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with cervical spinal cord injuries who are seeking improved hand and arm functionality.
Not a fit: Patients with spinal cord injuries at levels other than cervical or those with complete paralysis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly enhance the recovery of hand and arm function for patients with spinal cord injuries.
How similar studies have performed: Previous research has shown promising results with optogenetic approaches in animal models, indicating potential for success in this novel application.
Where this research is happening
SEATTLE, UNITED STATES
- UNIVERSITY OF WASHINGTON — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MORITZ, CHET T. — UNIVERSITY OF WASHINGTON
- Study coordinator: MORITZ, CHET T.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.